If you made any changes in Pure these will be visible here soon.

Research Output 2015 2019

2019

Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: a decision analysis study

Doan, T. N., Fox, G. J., Meehan, M. T., Scott, N., Ragonnet, R., Viney, K., Trauer, J. M. & McBryde, E. S., 1 Jan 2019, In : Journal of Antimicrobial Chemotherapy. 74, 1, p. 218-227 10 p., dky403.

Research output: Contribution to journalArticleResearchpeer-review

2018

Appropriate comparisons of tuberculosis latency structures with empiric data

Trauer, J. M., Ragonnet, R. & McBryde, E. S., 1 Jul 2018, In : The Lancet Infectious Diseases. 18, 7, p. 720-721 2 p.

Research output: Contribution to journalLetterOtherpeer-review

Methods used in the spatial analysis of tuberculosis epidemiology: A systematic review 11 Medical and Health Sciences 1117 Public Health and Health Services Sally Blower; Gerardo Chowell

Shaweno, D., Karmakar, M., Alene, K. A., Ragonnet, R., Clements, A. C., Trauer, J. M., Denholm, J. T. & McBryde, E. S., 18 Oct 2018, In : BMC Medicine. 16, 1, 18 p., 193.

Research output: Contribution to journalReview ArticleResearchpeer-review

Open Access
File
2017

A user-friendly mathematical modelling web interface to assist local decision making in the fight against drug-resistant tuberculosis

Ragonnet, R., Trauer, J. M., Denholm, J. T., Marais, B. J. & McBryde, E. S., 30 May 2017, In : BMC Infectious Diseases. 17, 1, 5 p., 374.

Research output: Contribution to journalLetterOtherpeer-review

Open Access
File

Estimating the time to diagnosis and the chance of spontaneous clearance during acute hepatitis C in human immunodeficiency virus-infected individuals

Ragonnet, R., Deuffic-Burban, S., Boesecke, C., Guiguet, M., Lacombe, K., Guedj, J., Rockstroh, J. K. & Yazdanpanah, Y., 1 Jan 2017, In : Open Forum Infectious Diseases. 4, 1, 7 p., ofw235.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

High rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from?

Ragonnet, R., Trauer, J. M., Denholm, J. T., Marais, B. J. & Mcbryde, E. S., 6 Jan 2017, In : BMC Infectious Diseases. 17, 1, 10 p., 36.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Is IPT more Effective in High Burden Settings? Modelling the Effect of TB Incidence on IPT Impact

Ragonnet, R., Trauer, J. M., Mcbryde, E. S., Houben, R. M. G. J., Denholm, J. T., Handel, A. & Sumner, T., Jan 2017, In : International Journal of Tuberculosis and Lung Disease. 21, 1, p. 60-66 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Maximising value for money of tuberculosis investment in the Philippines

Garfin, A. M. C., Gaviola, D. M., Camacho, E., Nalda, R., Mantala, M., Magboo, S., Yadav, R., Doan, T. N., Trauer, J., Ragonnet, R. & McBryde, E., Jan 2017, Manila Philippines: Department of Health Department of Health Philippines. 108 p.

Research output: Book/ReportCommissioned ReportResearch

Open Access
File

Modular programming for tuberculosis control, the "AuTuMN" platform

Trauer, J. M., Ragonnet, R., Doan, T. N. & McBryde, E. S., 7 Aug 2017, In : BMC Infectious Diseases. 17, 1, 12 p., 546.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Optimally capturing latency dynamics in models of tuberculosis transmission

Ragonnet, R., Trauer, J. M., Scott, N., Meehan, M. T., Denholm, J. T. & McBryde, E. S., 1 Dec 2017, In : Epidemics. 21, p. 39-47 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Optimising strategic investments in tuberculosis in the Republic of Bulgaria

Trauer, J., Doan, T. N., Ragonnet, R., McBryde, E., Varleva, T., Zamfirova, M., Tyufekchieva, M., Keshelava, A., Todorova, C., Ivanova, T., Gavazova, B. & Hristov, K., Jun 2017, Sofia Bulgaria: Ministry of Health, Republic of Bulgaria. 98 p.

Research output: Book/ReportCommissioned ReportResearch

Strategic investment in tuberculosis control: maximising impact of future programs in Fiji

Underwood, F., Taylor, V., Lindsey, R., Kalo, J., Namedre, M., Daulako, M., Yadav, S., Trauer, J., Doan, T. N., McBryde, E. & Ragonnet, R., Feb 2017, Suva Fiji: Ministry of Health of Fiji. 119 p.

Research output: Book/ReportCommissioned ReportResearch

The risk of global epidemic replacement with drug-resistant Mycobacterium tuberculosis strains

Mcbryde, E. S., Meehan, M. T., Doan, T. N., Ragonnet, R., Marais, B. J., Guernier, V. & Trauer, J. M., Mar 2017, In : International Journal of Infectious Diseases. 56, p. 14-20 7 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

Open Access
File
2016

Risk of active tuberculosis in the five years following infection ⋯ 15%?

Trauer, J. M., Moyo, N., Tay, E-L., Dale, K., Ragonnet, R., Mcbryde, E. S. & Denholm, J., 1 Feb 2016, In : Chest. 149, 2, p. 516-525 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Scenario analysis for programmatic tuberculosis control in Western Province, Papua New Guinea

Trauer, J. M., Denholm, J. T., Waseem, S., Ragonnet, R. & Mcbryde, E. S., 15 Jun 2016, In : American Journal of Epidemiology. 183, 12, p. 1138-1148 11 p.

Research output: Contribution to journalArticleResearchpeer-review

2015

Vaccination Programs for Endemic Infections: Modelling Real versus Apparent Impacts of Vaccine and Infection Characteristics

Ragonnet, R., Trauer, J. M., Denholm, J. T., Geard, N. L., Hellard, M. & Mcbryde, E. S., 20 Oct 2015, In : Scientific Reports. 5, 11 p., 15468 .

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File